(Q37494202)

20 August 2017

1 reference

title

Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review (English)

1 reference

20 August 2017

0 references

1 reference

1 reference

1 reference

Diana R Chirovsky

1

1 reference

20 August 2017

Veronika Fedirko

2

1 reference

20 August 2017

Yadong Cui

3

1 reference

20 August 2017

Vasilisa Sazonov

4

1 reference

20 August 2017

Philip Barter

5

1 reference

20 August 2017

1 August 2009

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

20 August 2017

1 reference

20 August 2017

16

1 reference

20 August 2017

4

1 reference

20 August 2017

404-423

1 reference

Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?

20 August 2017

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Risk factors for subclinical carotid atherosclerosis in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts. The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health Study (CHS) investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Multivariate analysis of the twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study and the usefulness of high density lipoprotein cholesterol percentage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Ischemic heart disease, atherosclerosis, and longevity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol and coronary heart disease in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Research on plasma lipoproteins: Theoretical aspects and relevance to clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Short-term all-cause mortality and its determinants in elderly male populations in Finland, The Netherlands, and Italy: the FINE Study. Finland, Italy, Netherlands Elderly Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell Cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Total but not high-density lipoprotein cholesterol is consistently associated with coronary heart disease mortality in elderly men in Finland, Italy, and The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Lipid levels and the risk of ischemic stroke in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Association of lipids and lipoprotein level with total mortality and mortality caused by cardiovascular and cancer diseases (Poland and United States collaborative study on cardiovascular epidemiology).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Epidemiological aspects of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

HDL cholesterol and mortality in Finnish men with special reference to alcohol intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

HDL serum cholesterol and 24-year mortality of men in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Risk factors and the incidence of coronary artery disease in young middle-aged Japanese men: results from a 10-year cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Sex differences in the relation of HDL cholesterol to progression of carotid intima-media thickness: the Los Angeles Atherosclerosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Risk factors for ischemic stroke: Dubbo Study of the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Cholesterol and the risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: the tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Plasma concentrations of high-density lipoprotein (HDL)-2 and HDL-3 in myocardial infarction survivors and in control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Serum lipoproteins in patients with myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The significance of serum HDL phospholipid levels in angiographically defined coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Genetic predisposition, nongenetic risk factors, and coronary infarct

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Serum lipids and anthropometric factors related to the prevalence of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Effect of high-density lipoprotein cholesterol levels on carotid artery geometry in a Mediterranean female population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Low HDL-C: a secondary target of dyslipidemia therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol: an emerging target for stroke treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein as a therapeutic target: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Bezafibrate in men with lower extremity arterial disease: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The paradox of dysfunctional high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Optimal therapy for acute coronary syndromes: the more the better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Disorders in high-density metabolism with insulin resistance and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Laboratory assessment of HDL heterogeneity and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

In vivo protection against endotoxin by plasma high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoproteins and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

HDL, its enzymes and its potential to influence lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

Protein composition determines the anti-atherogenic properties of HDL in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32832C8891

10.1097/HJR.0B013E32832C8891

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference